Jefferies Financial Group’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-293,670
Closed -$2.33M – 1905
2026
Q2
$2.33M Buy
293,670
+205,870
+234% +$1.31M 0.02% 635
2026
Q1
$509K Hold
87,800
– – ﹤0.01% 1204
2025
Q4
$689K Buy
+87,800
New +$691K ﹤0.01% 1240

Other funds holding XERS

Jefferies Financial Group's XERS Position: Q3 2026 in Review

Jefferies Financial Group sold out of Xeris Biopharma Holdings (XERS) in Q3 2026, closing a stake of 293,670 shares — an estimated $2.33M sold.

Jefferies Financial Group first reported a position in XERS in Q4 2025 and held it in 3 quarters. The position peaked at $2.33M in Q2 2026. 248 funds tracked by Wall St. Rank hold XERS as of Q3 2026.

  • Jefferies Financial Group reported no remaining Xeris Biopharma Holdings position as of Q3 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 293,670 Xeris Biopharma Holdings shares in Q3 2026, an estimated $2.33M.
  • Jefferies Financial Group first reported a position in Xeris Biopharma Holdings in Q4 2025 and held it in 3 quarters.
  • Jefferies Financial Group's Xeris Biopharma Holdings position peaked at $2.33M in Q2 2026.
  • 248 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2026.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.